
|Articles|June 22, 2011
- Psychiatric Times Vol 28 No 6
- Volume 28
- Issue 6
Einstein’s Happiest Moment -for Susanne
Author(s)Richard M. Berlin, MD
"Einstein’s happiest moment...occurred when he realized...a falling man falling...beside a falling apple..."
Advertisement
POETRY OF THE TIMES
Einstein’s happiest moment
occurred when he realized
a falling man falling
beside a falling apple
could also be described
as an apple and a man at rest
while the world rises around them.
And my happiest moment
occurred when I realized
you were falling for me,
right down to the core, and the rest,
relatively speaking, has flown past
faster than the speed of light.
Articles in this issue
over 15 years ago
Feeling Socially Safeover 15 years ago
Avoiding SRI Discontinuation Syndromeover 15 years ago
Drs McGlashan and Woods Respond to Dr Feinbergover 15 years ago
Obama Drug Misuse Strategy Targets Physician Educationover 15 years ago
Alfred M. Freedman, MD, 1917-2011over 15 years ago
Is It Treatment-Refractory Schizophrenia . . . And if It Is?over 15 years ago
Are We Training Psychiatrists to Provide Only Medication Management?over 15 years ago
Effects of Early Parental DepressionAdvertisement
Related to this article

Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.

Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.

Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.

How genes and early stress interact to shape antisocial behavior, from dopamine and serotonin pathways to MAOA and oxytocin findings.

Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.

Overlooking how hearing loss and sign language shape the Mental Status Examination can make language deprivation look like psychosis, authors warn.

Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psychiatric Pipeline in Review: Quarter 3, 2026
2
VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027
3
Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression
4
September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News
5

